Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

1-24 of 24 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

Multicriteria optimization of radiation therapy: Towards empowerment and standardization of reverse planning for head and neck squamous cell carcinoma.
Tonneau M, Roos M, Cayez R, Wagner A, Leguillette C, Le Deley MC, Lals S, Martinage G, Pasquier D, Mirabel X, Lacornerie T, Liem X
Cancer Radiother, 28(4):317-322, 26 Jun 2024
Cited by: 0 articles | PMID: 38937203
Add to export list
Multi-institutional prognostic modeling of survival outcomes in NSCLC patients treated with first-line immunotherapy using radiomics.
Yolchuyeva S, Ebrahimpour L, Tonneau M, Lamaze F, Orain M, Coulombe F, Malo J, Belkaid W, Routy B, Joubert P, Manem VS
J Transl Med, 22(1):42, 10 Jan 2024
Cited by: 2 articles | PMID: 38200511 | PMCID: PMC10777540
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
CXCL13 Positive Cells Localization Predict Response to Anti-PD-1/PD-L1 in Pulmonary Non-Small Cell Carcinoma.
Vahidian F, Lamaze FC, Bouffard C, Coulombe F, Gagné A, Blais F, Tonneau M, Orain M, Routy B, Manem VSK, Joubert P
Cancers (Basel), 16(4):708, 07 Feb 2024
Cited by: 1 article | PMID: 38398098 | PMCID: PMC10887067
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Imaging-Based Biomarkers Predict Programmed Death-Ligand 1 and Survival Outcomes in Advanced NSCLC Treated With Nivolumab and Pembrolizumab: A Multi-Institutional Study.
Yolchuyeva S, Giacomazzi E, Tonneau M, Lamaze F, Orain M, Coulombe F, Malo J, Belkaid W, Routy B, Joubert P, Manem VSK
JTO Clin Res Rep, 4(12):100602, 18 Nov 2023
Cited by: 1 article | PMID: 38124790 | PMCID: PMC10730368
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The Cross-Scale Association between Pathomics and Radiomics Features in Immunotherapy-Treated NSCLC Patients: A Preliminary Study.
Dia AK, Ebrahimpour L, Yolchuyeva S, Tonneau M, Lamaze FC, Orain M, Coulombe F, Malo J, Belkaid W, Routy B, Joubert P, Després P, Manem VSK
Cancers (Basel), 16(2):348, 13 Jan 2024
Cited by: 1 article | PMID: 38254838 | PMCID: PMC10813866
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma.
Hes C, Desilets A, Tonneau M, El Ouarzadi O, De Figueiredo Sousa M, Bahig H, Filion É, Nguyen-Tan PF, Christopoulos A, Benlaïfaoui M, Derosa L, Alves Costa Silva C, Ponce M, Malo J, Belkad W, Charpentier D, Aubin F, Hamilou Z, Jamal R, [...] Routy B
Oral Oncol, 148:106623, 24 Nov 2023
Cited by: 4 articles | PMID: 38006691
Add to export list
The prognostic impact of KRAS, TP53, STK11 and KEAP1 mutations and their influence on the NLR in NSCLC patients treated with immunotherapy.
Proulx-Rocray F, Routy B, Nassabein R, Belkaid W, Tran-Thanh D, Malo J, Tonneau M, Ouarzadi OE, Florescu M, Tehfe M, Blais N
Cancer Treat Res Commun, 37:100767, 10 Oct 2023
Cited by: 6 articles | PMID: 37832364
Add to export list
Management of head and neck carcinomas with synchronous or metachronous oligometastatic disease: Role of locoregional radiotherapy and metastasis-directed radiotherapy.
Tonneau M, Nebbache R, Larnaudie A, Thureau S, Pointreau Y, Blanchard P, Thariat J
Cancer Radiother, 28(1):83-92, 22 Aug 2023
Cited by: 1 article | PMID: 37620212
Add to export list
Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors' response in non-small cell lung cancer: a multicenter cohort study.
Tonneau M, Phan K, Manem VSK, Low-Kam C, Dutil F, Kazandjian S, Vanderweyen D, Panasci J, Malo J, Coulombe F, Gagné A, Elkrief A, Belkaïd W, Di Jorio L, Orain M, Bouchard N, Muanza T, Rybicki FJ, Kafi K, [...] Routy B
Front Oncol, 13:1196414, 20 Jul 2023
Cited by: 1 article | PMID: 37546399 | PMCID: PMC10400292
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study.
Yolchuyeva S, Giacomazzi E, Tonneau M, Ebrahimpour L, Lamaze FC, Orain M, Coulombe F, Malo J, Belkaid W, Routy B, Joubert P, Manem VSK
Cancers (Basel), 15(15):3829, 28 Jul 2023
Cited by: 5 articles | PMID: 37568646 | PMCID: PMC10417039
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Radiomics approaches to predict PD-L1 and PFS in advanced non-small cell lung patients treated with immunotherapy: a multi-institutional study.
Yolchuyeva S, Giacomazzi E, Tonneau M, Lamaze F, Orain M, Coulombe F, Malo J, Belkaid W, Routy B, Joubert P, Manem VSK
Sci Rep, 13(1):11065, 08 Jul 2023
Cited by: 7 articles | PMID: 37422576 | PMCID: PMC10329671
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A competing risk analysis of the patterns and risk factors of recurrence in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy.
Tonneau M, Richard C, Routy B, Campeau MP, Vu T, Filion E, Roberge D, Mathieu D, Doucet R, Beliveau-Nadeau D, Bahig H
Radiother Oncol, 185:109697, 09 May 2023
Cited by: 0 articles | PMID: 37169303
Add to export list
Short- and Long-term Repercussions of Vancomycin on Immune Surveillance and the Efficacy of Antitumor Treatments.
Paz Del Socorro T, Tonneau M, Pasquier D, Chamaillard M
Cancer J, 29(2):98-101, 01 Mar 2023
Cited by: 0 articles | PMID: 36957980
Add to export list Review
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer.
Auclin E, Benitez-Montanez J, Tagliamento M, Parisi F, Gorria T, Garcia-Campelo R, Dempsey N, Pinato DJ, Reyes R, Albarrán-Artahona V, Dall'Olio F, Soldato D, Hendriks L, Nana FA, Tonneau M, Lopez-Castro R, Nadal E, Kazandjian S, Muanza T, [...] Mezquita L
Lung Cancer, 178:116-122, 04 Feb 2023
Cited by: 8 articles | PMID: 36812760
Add to export list
Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors.
Tonneau M, Nolin-Lapalme A, Kazandjian S, Auclin E, Panasci J, Benlaifaoui M, Ponce M, Al-Saleh A, Belkaid W, Naimi S, Mihalcioiu C, Watson I, Bouin M, Miller W, Hudson M, Wong MK, Pezo RC, Turcotte S, Bélanger K, [...] Routy B
Oncoimmunology, 11(1):2096535, 07 Jul 2022
Cited by: 11 articles | PMID: 35832043 | PMCID: PMC9272833
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Current Therapy for Metastatic Head and Neck Cancer: Evidence, Opportunities, and Challenges.
Wise-Draper TM, Bahig H, Tonneau M, Karivedu V, Burtness B
Am Soc Clin Oncol Educ Book, 42:1-14, 01 Apr 2022
Cited by: 24 articles | PMID: 35486888
Add to export list Review
Stereotactic Ablative Radiotherapy for oligo-progressive disease refractory to systemic therapy in Non-Small Cell Lung Cancer: A registry-based phase II randomized trial (SUPPRESS-NSCLC).
Bahig H, Tonneau M, Blais N, Wong P, Filion E, Campeau MP, Vu T, Al-Saleh A, Tehfé M, Florescu M, Roberge D, Masucci L, Richard C, Menard C, Routy B
Clin Transl Radiat Oncol, 33:115-119, 05 Jan 2022
Cited by: 5 articles | PMID: 35243022 | PMCID: PMC8881202
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Stereotactic body radiotherapy for intramedullary metastases: a retrospective series at the Oscar Lambret center and a systematic review.
Tonneau M, Mouttet-Audouard R, Le Tinier F, Mirabel X, Pasquier D
BMC Cancer, 21(1):1168, 30 Oct 2021
Cited by: 4 articles | PMID: 34717570 | PMCID: PMC8557534
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
[Radiotherapy for patients with early-stage glottic squamous cell carcinoma of the larynx: Interest of hypofractionation?]
Tonneau M, Matta R, Lals S, Mirabel X, Crop F, Lacornerie T, Pasquier D, Escande A, Liem X
Cancer Radiother, 25(8):801-810, 27 Apr 2021
Cited by: 1 article | PMID: 33931299
Add to export list Review
[Stereotactic body radiotherapy for locally advanced pancreatic cancer: A systemic review].
Tonneau M, Lacornerie T, Mirabel X, Pasquier D
Cancer Radiother, 25(3):283-295, 07 Jan 2021
Cited by: 4 articles | PMID: 33423968
Add to export list Review
The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: A systematic review.
Tonneau M, Elkrief A, Pasquier D, Paz Del Socorro T, Chamaillard M, Bahig H, Routy B
Radiother Oncol, 156:1-9, 01 Nov 2020
Cited by: 28 articles | PMID: 33137398
Add to export list Review
Prevalence of psychoactive substances in truck drivers in the Nord-Pas-de-Calais region (France).
Labat L, Fontaine B, Delzenne C, Doublet A, Marek MC, Tellier D, Tonneau M, Lhermitte M, Frimat P
Forensic Sci Int, 174(2-3):90-94, 06 Apr 2007
Cited by: 19 articles | PMID: 17418990
Add to export list
Effect of positive end-expiratory pressure in severe acute asthma.
Mathieu M, Tonneau MC, Zarka D, Sartene R
Crit Care Med, 15(12):1164, 01 Dec 1987
Cited by: 4 articles | PMID: 3315468
Add to export list
[Parotid thorotrastoma. An anatomo-clinical case].
Verhaeghe M, Adenis L, Demaille A, Tonneau M
J Chir (Paris), 100(4):271-280, 01 Oct 1970
Cited by: 1 article | PMID: 5491630
Add to export list

1-24 of 24 results

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

Multicriteria optimization of radiation therapy: Towards empowerment and standardization of reverse planning for head and neck squamous cell carcinoma.

Multi-institutional prognostic modeling of survival outcomes in NSCLC patients treated with first-line immunotherapy using radiomics.

CXCL13 Positive Cells Localization Predict Response to Anti-PD-1/PD-L1 in Pulmonary Non-Small Cell Carcinoma.

Imaging-Based Biomarkers Predict Programmed Death-Ligand 1 and Survival Outcomes in Advanced NSCLC Treated With Nivolumab and Pembrolizumab: A Multi-Institutional Study.

The Cross-Scale Association between Pathomics and Radiomics Features in Immunotherapy-Treated NSCLC Patients: A Preliminary Study.

Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma.

The prognostic impact of KRAS, TP53, STK11 and KEAP1 mutations and their influence on the NLR in NSCLC patients treated with immunotherapy.

Management of head and neck carcinomas with synchronous or metachronous oligometastatic disease: Role of locoregional radiotherapy and metastasis-directed radiotherapy.

Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors' response in non-small cell lung cancer: a multicenter cohort study.

A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study.

Radiomics approaches to predict PD-L1 and PFS in advanced non-small cell lung patients treated with immunotherapy: a multi-institutional study.

A competing risk analysis of the patterns and risk factors of recurrence in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy.

Short- and Long-term Repercussions of Vancomycin on Immune Surveillance and the Efficacy of Antitumor Treatments.

Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer.

Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors.

Current Therapy for Metastatic Head and Neck Cancer: Evidence, Opportunities, and Challenges.

Stereotactic Ablative Radiotherapy for oligo-progressive disease refractory to systemic therapy in Non-Small Cell Lung Cancer: A registry-based phase II randomized trial (SUPPRESS-NSCLC).

Stereotactic body radiotherapy for intramedullary metastases: a retrospective series at the Oscar Lambret center and a systematic review.

[Radiotherapy for patients with early-stage glottic squamous cell carcinoma of the larynx: Interest of hypofractionation?]

[Stereotactic body radiotherapy for locally advanced pancreatic cancer: A systemic review].

The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: A systematic review.

Prevalence of psychoactive substances in truck drivers in the Nord-Pas-de-Calais region (France).

Effect of positive end-expiratory pressure in severe acute asthma.

[Parotid thorotrastoma. An anatomo-clinical case].

Partnerships & funding